AR241515A1 - Procedimiento de preparacion de composiciones farmaceuticas estables que contienen nicorandil. - Google Patents

Procedimiento de preparacion de composiciones farmaceuticas estables que contienen nicorandil.

Info

Publication number
AR241515A1
AR241515A1 AR85302556A AR30255685A AR241515A1 AR 241515 A1 AR241515 A1 AR 241515A1 AR 85302556 A AR85302556 A AR 85302556A AR 30255685 A AR30255685 A AR 30255685A AR 241515 A1 AR241515 A1 AR 241515A1
Authority
AR
Argentina
Prior art keywords
production
acid
sugar
preparation
nicorandil preparation
Prior art date
Application number
AR85302556A
Other languages
English (en)
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of AR241515A1 publication Critical patent/AR241515A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE COMPOSICIONES FARMACEUTICAS ESTABLES QUE CONTINEN NICORANDIL DE FORMULA I. COMPRENDE LAS ETAPAS OPERATORIAS DE MEZCLAR NICORANDIL CON UN AZUCAR FINAMENTE DESMENUZADO Y/O CON UN ACIDO ORGANICO EN POLVO, ELEGIDO ENTRE LOS ACIDOS FUMARICO, OXALICO, SALICILICO, TARTARICO, GLUTARICO Y ACIDO DIBASICOS EQUIVALENTES, Y PROCESAR LA COMPOSICION A PARTIR DE LA MEZCLA. EL AZUCAR ESTA ELEGIDO ENTRE MANITOL, LACTOSA, SACAROSA, GLUCOSA, GALACTOSA, MALTOSA Y FRUCTOSA.
AR85302556A 1984-12-17 1985-12-12 Procedimiento de preparacion de composiciones farmaceuticas estables que contienen nicorandil. AR241515A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP59265888A JPH0653658B2 (ja) 1984-12-17 1984-12-17 安定な錠剤の製造法
JP14968885 1985-07-08
JP21327785 1985-09-26

Publications (1)

Publication Number Publication Date
AR241515A1 true AR241515A1 (es) 1992-08-31

Family

ID=27319808

Family Applications (1)

Application Number Title Priority Date Filing Date
AR85302556A AR241515A1 (es) 1984-12-17 1985-12-12 Procedimiento de preparacion de composiciones farmaceuticas estables que contienen nicorandil.

Country Status (23)

Country Link
US (1) US4803213A (es)
EP (1) EP0185347B1 (es)
JP (1) JPH0653658B2 (es)
KR (1) KR930007251B1 (es)
CN (1) CN1007209B (es)
AR (1) AR241515A1 (es)
AT (1) ATE54050T1 (es)
AU (1) AU579431B2 (es)
BA (1) BA98214B1 (es)
CA (1) CA1255227A (es)
DE (1) DE3578373D1 (es)
DK (1) DK167171B1 (es)
FI (1) FI84781C (es)
HK (1) HK65493A (es)
HU (1) HU195731B (es)
IE (1) IE59158B1 (es)
MX (1) MX166095B (es)
NO (1) NO171826C (es)
PT (1) PT81680B (es)
RU (1) RU1811401C (es)
SG (1) SG52493G (es)
YU (1) YU45292B (es)
ZA (1) ZA859390B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
KR950010150B1 (ko) * 1986-01-14 1995-09-11 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 함유 주사제의 안정화 방법
KR940000232B1 (ko) * 1986-01-17 1994-01-12 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 제제의 안정화 방법
GR871267B (en) * 1986-08-18 1987-12-24 Chugai Pharmaceutical Co Ltd Method for the manufacture of a pharmaceutical preparation for administration by percutaneous absortion
US4940580A (en) * 1986-11-03 1990-07-10 Schering Corporation Sustained release labetalol tablets
CA1322957C (en) * 1988-03-30 1993-10-12 Hitoshi Yamauchi Cyclic amp derivative ointments
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
DK0902777T4 (da) 1996-04-16 2004-10-11 Takeda Chemical Industries Ltd D-mannitol og dets fremstilling
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US20010014340A1 (en) * 1996-06-14 2001-08-16 Motohiro Ohta Intrabuccally rapidly disintegrating tablet
KR100481583B1 (ko) * 1996-06-14 2005-07-12 교와 핫꼬 고교 가부시끼가이샤 구강내에서빠르게붕괴하는정제
IT1293835B1 (it) * 1997-08-08 1999-03-10 Foscama Biomed Chim Farma Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
KR100483080B1 (ko) * 2001-09-21 2005-04-14 한인규 염산·베타인(betaine·HCl), 판크레아틴, 제2인산 칼슘, 크롬 피콜리네이트, 락토바실러스속·비피도박테리아속·스트렙토코커스속·프럭토 올리고당, 비타민, 미네랄을 유효성분으로 구성된 것을 특징으로 하는 증체개선용 영양강화 사료첨가제
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
JP4235149B2 (ja) 2004-07-02 2009-03-11 インターナショナル・ビジネス・マシーンズ・コーポレーション ノートブック型コンピュータ
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ728442A (en) * 2004-10-21 2018-05-25 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
CN100417381C (zh) * 2006-02-09 2008-09-10 西安力邦医药科技有限责任公司 尼可地尔冻干粉的制备方法
US20090076095A1 (en) * 2007-09-15 2009-03-19 Protia, Llc Deuterium-enriched nicorandil
GB0720516D0 (en) * 2007-10-18 2007-11-28 Cadbury Schweppes Plc Comestible products
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
UY33173A (es) * 2010-01-08 2011-07-29 Eurand Inc
CN111606847B (zh) * 2020-05-26 2021-12-31 中国科学院上海药物研究所 尼可地尔与1-羟基-2-萘甲酸的共晶及其制备方法和应用
CN114732792A (zh) * 2022-03-25 2022-07-12 北京诺康达医药科技股份有限公司 一种尼可地尔口腔崩解片及其制备方法
CN115317456A (zh) * 2022-08-17 2022-11-11 北京科源创欣科技有限公司 一种尼可地尔片组合物及其制备方法
CN115282123B (zh) * 2022-09-13 2023-11-03 南京比逊医药科技有限公司 一种稳定的尼可地尔制剂的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168438A (en) * 1962-08-09 1965-02-02 Synergistics Inc Vasodilation by nitric acid ester derivatives of nicotinic acid
US3332848A (en) * 1963-07-10 1967-07-25 Hoffmann La Roche Microcrystalline cellulose with starch in niacinamide ascorbic acid tablet granulations
US3577491A (en) * 1968-01-02 1971-05-04 Miles Lab Tableting
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
AU509591B2 (en) * 1976-04-02 1980-05-15 Chugai Seiyaku Kabushiki Kaisha Pyridine derivatives
JPS599539B2 (ja) * 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
US4490377A (en) * 1980-07-29 1984-12-25 Syntex (U.S.A.) Inc. Acid stabilized compositions of thieno-pyridine derived compounds
EP0045238B1 (en) * 1980-07-29 1986-10-01 Sanofi S.A. Acid stabilized compositions of thieno-pyridine derived compounds and process for preventing degradation of such compounds
US4382091A (en) * 1981-04-30 1983-05-03 Syntex (U.S.A.) Inc. Stabilization of 1-substituted imidazole derivatives in talc
JPS5885819A (ja) * 1981-11-17 1983-05-23 Chugai Pharmaceut Co Ltd 気管支拡張剤
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
KR860004633A (ko) 1986-07-11
NO855048L (no) 1986-06-18
DE3578373D1 (de) 1990-08-02
KR930007251B1 (ko) 1993-08-04
IE59158B1 (en) 1994-01-12
BA98214B1 (bs) 1999-08-02
CA1255227A (en) 1989-06-06
DK583385D0 (da) 1985-12-16
SG52493G (en) 1993-08-06
HU195731B (en) 1988-07-28
ATE54050T1 (de) 1990-07-15
YU45292B (en) 1992-05-28
EP0185347B1 (en) 1990-06-27
CN1007209B (zh) 1990-03-21
RU1811401C (ru) 1993-04-23
NO171826C (no) 1993-05-12
YU197385A (en) 1988-04-30
AU5076285A (en) 1986-06-26
FI84781C (fi) 1992-01-27
DK583385A (da) 1986-06-18
EP0185347A2 (en) 1986-06-25
FI855032A0 (fi) 1985-12-17
MX166095B (es) 1992-12-18
ZA859390B (en) 1986-08-27
AU579431B2 (en) 1988-11-24
PT81680A (en) 1986-01-01
HK65493A (en) 1993-07-16
IE853176L (en) 1986-06-17
NO171826B (no) 1993-02-01
FI84781B (fi) 1991-10-15
HUT40567A (en) 1987-01-28
EP0185347A3 (en) 1987-04-22
US4803213A (en) 1989-02-07
JPH0653658B2 (ja) 1994-07-20
JPS61143316A (ja) 1986-07-01
FI855032A (fi) 1986-06-18
DK167171B1 (da) 1993-09-13
CN85109190A (zh) 1986-07-16
PT81680B (pt) 1988-11-30

Similar Documents

Publication Publication Date Title
AR241515A1 (es) Procedimiento de preparacion de composiciones farmaceuticas estables que contienen nicorandil.
NO921955L (no) Nye d-vitaminforbindelser og fremgangsmaate til fremstilling av samme
DK104694A (da) Fremgangsmåde til fremstilling af 4-demethoxy-7-deoxy-daunomycinon eller 4-demethoxy-danomycinon
DK153546C (da) Analogifremgangsmaade til fremstilling af l-n-n-propylpipecolinsyre-2,6-xylidid eller et farmaceutisk acceptabelt, vandoploeseligt salt deraf
ATE101520T1 (de) Stabilisiertes arzneimittel und verfahren zu dessen herstellung.
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
ATE52912T1 (de) Bindemittel-verduenner-zusammensetzung und verfahren zu ihrer herstellung.
NO180147C (no) Fremgangsmåte for fremstilling av HDLC eller et liposom innbefattende et polyen-antisopp-antibiotikum og et lipid
ES2074492T3 (es) Derivados de acidos biliares, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
YU221889A (en) Process for producing new pharmaceutical mixture
FI861655A0 (fi) Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi
ATE74768T1 (de) Feste pharmazeutische zubereitung und verfahren zur herstellung derselben.
ES2157289T3 (es) Procedimiento para la preparacion de 2'-desoxi-2',2'-difluoronucleosidos.
ES2054738T3 (es) Derivados de acido 3-desmetil-4-fluoromevalonico, procedimiento para su preparacion, preparados farmaceuticos a base de estos compuestos, su empleo y productos intermedios.
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
KR890002147A (ko) 카스타노스페르민 에스테르 및 글리코시드
MX9203642A (es) Compuestos substituidos del acido 1,3,4,9-tetrahidropirano (3,4-b)-indol-1-acetico y composiciones farmaceuticas que los contienen.
ES2094623T3 (es) Procedimiento estereoselectivo para la preparacion de 2-desoxi-2,2-difluoro-d-ribofuranosil-3,5-hidroxi protegido-1-alquil y aril-sulfonatos intermedios enriquecidos en el anomero beta.
PT88312A (pt) Processo para a preparacao de glucosidos derivados da 4'-deshidroxiepipodofilotoxina e de composicoes farmaceuticas que os contem
DK257083A (da) Mikroorganismestammen chromobacterium violaceum, farmaceutisk aktive forbindelser fremstillet med stammen, fremgangsmaade til fremstilling af forbindelserne og disses anvendelse som laegemidler
AR245440A1 (es) Un metodo para decolorar un acido alcanosulfonico o arenosulfonico.
ATE75479T1 (de) N-acetyl-3-fluorneuraminsaeurederivate und deren herstellung.
JPS5655397A (en) Aminobenzoic acid ester derivative, and physiologically active agent containing said derivative
ES2001430A6 (es) Nuevo metodo de preparacion de la d-ribosa
GR3004272T3 (es)